ABSTRACT
The rise of genetic technologies has transformed the landscape of reproduction, giving birth to the concept of “designer families” where parents can select or influence the genetic traits of their future children. This development poses complex legal and ethical questions regarding parenthood, identity, and the limits of personal choice. This paper explores the evolving legal framework surrounding assisted reproduction and genetic selection, focusing on the conflict between individual reproductive freedom and broader questions of justice. As genetic tools become more precise and accessible, legal systems face challenges in regulating the rights and responsibilities of biological and intended parents, especially in cases involving surrogacy, donor gametes, and gene editing. The paper further examines whether such technologies risk reinforcing social inequalities by making genetic advantages available only to the privileged. Indian legal perspectives are examined alongside comparative approaches to identify gaps, contradictions, and possibilities for reform. This research argues for a nuanced, rights-based legal response that balances innovation with equity, ensuring the welfare of all parties involved most importantly, the child. By analyzing emerging legal trends and ethical tensions, the paper seeks to understand how law can adapt to the shifting realities of modern family creation.
KEYWORDS
Designer Families , Genetic Selection , Reproductive Rights , Bioethics , Parenthood Law.
INTRODUCTION
Advancements in reproductive genetics have reshaped the foundational ideas of family, inheritance, and parenthood. The rise of technologies like IVF (in vitro fertilization), PGD (preimplantation genetic diagnosis), and CRISPR gene editing has made it possible for parents to not only overcome infertility but also influence the genetic traits of their children. This has given rise to the term “designer families”—a concept that challenges conventional biological, ethical, and legal assumptions about reproduction and kinship. The central question this research addresses is that how should the law regulate emerging reproductive technologies in a manner that balances genetic choice, parental rights, child welfare, and social justice? As families are increasingly formed through assisted methods, traditional legal definitions of parentage, legitimacy, and the “best interests of the child” are being called into question.
This research is highly relevant in the context of India’s growing fertility industry and its ongoing legal reforms around surrogacy and ART. It also resonates globally, as nations grapple with regulating genetic interventions. The objective of this study is to analyze how legal systems are responding to these scientific developments, and whether existing frameworks are adequate.
The research methodology adopted is doctrinal, relying on analysis of statutes, case laws, policy papers, and academic literature from Indian and international sources.
Review of Literature
A growing body of literature has examined the intersection of genetics and reproductive law. Scholars have addressed the ethical dilemmas posed by gene editing (Savulescu, 2001), the commodification of the female body in surrogacy arrangements (Pande, 2009), and the legal ambiguity surrounding donor anonymity and child identity rights (Spar, 2005). In India, works have focused on the lack of legal protections in surrogacy contracts and the urgent need for ART regulation (Sama Resource Group reports, 2015–2020).
Judicial decisions such as Baby Manji Yamada v. Union of India (2008) and Jan Balaz v. Union of India (2010) have shed light on India’s legal struggles with cross-border surrogacy and undefined parental rights. Internationally, cases like Johnson v. Calvert (California, 1993) have clarified distinctions between genetic and gestational motherhood.
However, a notable gap exists in literature that connects these legal debates to broader theories of justice and inequality. Much of the discourse is either biomedical or narrowly legalistic, without critically exploring how designer reproduction could deepen social divides. This paper aims to bridge that gap by examining the legal anatomy of designer families through the lens of justice—both procedural and substantive—and suggesting a rights-based regulatory model.
Research Methodology
This study follows a doctrinal legal research method, which involves analyzing laws, judicial decisions, and academic opinions to understand how legal systems are responding to the emergence of designer families. The aim is to interpret existing laws and legal principles while identifying inconsistencies, gaps, and areas for reform. This method suits the topic as it does not rely on statistical data but rather on logical reasoning, precedent analysis, and theoretical perspectives.
Primary Sources : The research closely examines Indian legislation, including:
- The Assisted Reproductive Technology (Regulation) Act, 2021, which sets standards for ART clinics and gamete donors (1Th)
- The Surrogacy (Regulation) Act, 2021, which outlines conditions for altruistic surrogacy in India (1Th1)
Additionally, key judicial decisions are studied:
- Baby Manji Yamada v. Union of India (2008), which brought international surrogacy into legal spotlight (1Ba)
- Jan Balaz v. Union of India (2010), which exposed the ambiguity of citizenship and parentage in surrogate births (2Ja)
- Comparative reference is also made to Johnson v. Calvert (1993, USA), a landmark case distinguishing between genetic and gestational motherhood (1Jo)
Secondary Sources : The research incorporates scholarly writings from bioethics, family law, and feminist jurisprudence. Scholars like Amrita Pande have critiqued the commercialization of surrogacy in India, while Julian Savulescu has sparked debate on the ethical permissibility of genetic enhancement. Indian legal commentaries, law commission reports, and journal articles from reputed law reviews are consulted to enrich the analysis (1AM)
Analytical Tools and Approach
A comparative legal method is used to contrast Indian legal developments with those in jurisdictions like the UK, USA, and Canada. This helps in evaluating whether India’s current regulatory model adequately addresses the legal and ethical complexities of genetic selection.
The analysis is guided by principles of:
- Justice and equality, especially in terms of access to reproductive technologies.
- Autonomy, particularly the rights of intending parents and surrogate mothers.
- Child welfare, keeping in mind the long-term legal identity and psychological wellbeing of the child born through such technologies.
This layered and issue-based approach allows the research to move beyond black-letter law, engaging with broader normative questions around the future of law, family, and genetics.
Analysis / Discussion
Redefining Parenthood in the Age of Genetics
Traditional legal systems have long relied on biological and gestational connections to determine parentage. However, the emergence of technologies like IVF, gamete donation, surrogacy, and gene editing has created a rift between genetic, gestational, and intentional parenthood. Indian statutes, such as the Surrogacy (Regulation) Act, 2021 and the ART (Regulation) Act, 2021, attempt to define parentage in these new contexts but leave several grey areas.
For instance, the law recognizes the intending couple as the legal parents in altruistic surrogacy, even though they may lack any genetic connection with the child.¹ This raises the question—should intent take precedence over biology? The Gujarat High Court in Jan Balaz v. Union of India² did not resolve this conflict conclusively, especially where the surrogate and donor were different persons.
Internationally, Johnson v. Calvert³ (U.S.) adopted the “intended parent doctrine,” prioritizing the intention of the commissioning parents over gestation.
India seems to lean in this direction legislatively, but judicial clarity is lacking (htt24)
Genetic Selection and the Ethics of Choice
The concept of “designer babies” goes beyond overcoming infertility. It includes selecting traits like eye color, intelligence, or resistance to diseases. While gene editing technologies like CRISPR have not yet been legalized for human reproduction in India, the possibility raises critical legal and moral concerns.
Julian Savulescu’s theory of “procreative beneficence”⁴ suggests parents have a moral duty to select the best possible traits for their child. However, legal systems must weigh such ethical positions against constitutional values like equality and dignity. Allowing unrestricted genetic selection could lead to discrimination, eugenics, and widening socio-economic gaps where only the wealthy can afford “better” babies.
Currently, Indian law does not address gene editing in reproduction. The Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act, 1994, prohibits sex selection but does not speak to trait-based selection. This silence could become problematic as technologies evolve.
Child’s Welfare and Legal Identity
In all reproductive decisions, the child’s best interest must remain central. However, defining this interest in genetically constructed families is complex. Questions arise: Should a child have the right to know their genetic origin? What if a child is harmed due to failed gene editing? Who is liable?
The Supreme Court of India has recognized the right to identity and dignity under Article 21 of the Constitution.⁵ This could extend to a child’s right to know their genetic parents or the process through which they were born. However, the current legislative framework remains silent on these aspects.
In Baby Manji Yamada v. Union of India,⁶ the Court acknowledged the legitimacy of a child born through surrogacy but did not address deeper identity rights. As families become more genetically engineered, courts will be forced to grapple with these difficult questions.
Commercialization and Exploitation
India was once known as a global hub for commercial surrogacy, leading to exploitation of poor women. The 2021 Surrogacy Act outlawed commercial surrogacy, citing ethical and constitutional concerns. However, the law’s altruistic model still carries risks—economic coercion, emotional trauma, and unclear rights for surrogate mothers.
Furthermore, the booming fertility industry, often operating in regulatory grey zones, thrives on the promise of designer reproduction. Clinics may push expensive genetic testing and “elite donor” selection, subtly reinforcing caste, class, and beauty biases.
This raises constitutional concerns under Article 14 (equality) and Article 23 (prohibition of exploitation). A legal framework that merely shifts from overt commercial to veiled coercion cannot be said to uphold justice.
Gaps and Conflicts in Current Legal Framework
While the ART and Surrogacy Acts provide basic regulatory structure, they do not account for futuristic technologies like embryo editing, mitochondrial transfer, or full artificial wombs. There is also no clarity on international surrogacy, single parent commissioning via ART, or LGBTQ+ couples accessing genetic services.
Moreover, there is an absence of a unified statute governing parentage, rights of children born through ART, and ethical standards for genetic enhancement. This fragmented approach weakens enforcement and leads to interpretive confusion.
Findings / Results
- Intent-based parenthood is emerging as a global legal trend, but India lacks judicial consensus.
- Genetic selection is ethically debated but legally under-regulated.
- Child identity rights are not clearly articulated in Indian laws.
- Surrogate and donor protections are legally present but may not be practically enforceable due to socio-economic disparity.
- Future genetic technologies (like CRISPR) are not addressed at all in current Indian laws, leaving a vacuum that must be urgently filled.
Conclusion
The evolving reality of designer families compels us to rethink long-standing legal doctrines on parenthood, identity, and reproductive autonomy. While the Assisted Reproductive Technology and Surrogacy Acts mark progress, they are far from comprehensive. The lack of legal provisions on genetic enhancement, international ART arrangements, and the child’s right to origin highlights major legislative blind spots.
The answer to the central research question whether Indian law adequately regulates designer families is nuanced. Legally, India has taken steps toward regulating assisted reproduction, but it has yet to develop a mature, future-facing legal framework that addresses the complexities of genetics, justice, and identity in parenthood.
Recommendations
- A unified law on legal parenthood that factors in intention, genetics, and child welfare.
- Regulations for gene editing technologies before they enter clinical use.
- Recognition of identity and autonomy rights of children born through ART.
- Stronger enforcement mechanisms for surrogate and donor protections.
- Ethical oversight bodies with medical, legal, and social expertise.
Future scope lies in interdisciplinary dialogue—where law collaborates with science, ethics, and sociology to prepare for an era where genes may shape not just bodies, but the legal meaning of family itself.
Bibliography
(n.d.). Retrieved from 1. The Assisted Reproductive Technology (Regulation) Act, No. 42 of 2021, INDIA CODE (2021).
(n.d.). Retrieved from 1. The Surrogacy (Regulation) Act, No. 47 of 2021, INDIA CODE (2021).
(n.d.). Retrieved from 1. Baby Manji Yamada v. Union of India, (2008) 13 SCC 518.
(n.d.). Retrieved from 2. Jan Balaz v. Union of India, Special Civil Application No. 3020 of 2008, Gujarat High Court.
(n.d.). Retrieved from 1. Johnson v. Calvert, 851 P.2d 776 (Cal. 1993) (U.S.).
(n.d.). Retrieved from 1. AMRITA PANDE, WOMBS IN LABOR: TRANSNATIONAL COMMERCIAL SURROGACY IN INDIA (Columbia Univ. Press 2014).
(n.d.). Retrieved from https://www.economist.com/asia/2025/05/22/how-to-fix-indias-sclerotic-justice-system
By Jhanvi
SCHOOL OF EXCELLENCE IN LAW , TAMIL NADU DR.AMBEDKAR LAW UNIVERSITY , CHENNAI , TAMIL NADU .